119 related articles for article (PubMed ID: 25563188)
1. Label-free functional selectivity assays.
Ferrie AM; Goral V; Wang C; Fang Y
Methods Mol Biol; 2015; 1272():227-46. PubMed ID: 25563188
[TBL] [Abstract][Full Text] [Related]
2. Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells.
Fang Y; Ferrie AM
FEBS Lett; 2008 Mar; 582(5):558-64. PubMed ID: 18242178
[TBL] [Abstract][Full Text] [Related]
3. A label-free optical biosensor with microfluidics identifies an intracellular signalling wave mediated through the β(2)-adrenergic receptor.
Ferrie AM; Wang C; Deng H; Fang Y
Integr Biol (Camb); 2013 Oct; 5(10):1253-61. PubMed ID: 23989552
[TBL] [Abstract][Full Text] [Related]
4. Agonist-directed desensitization of the β2-adrenergic receptor.
Goral V; Jin Y; Sun H; Ferrie AM; Wu Q; Fang Y
PLoS One; 2011 Apr; 6(4):e19282. PubMed ID: 21541288
[TBL] [Abstract][Full Text] [Related]
5. Label-free biosensor assays in GPCR screening.
Grundmann M; Kostenis E
Methods Mol Biol; 2015; 1272():199-213. PubMed ID: 25563186
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells.
Fang Y; Li G; Ferrie AM
J Pharmacol Toxicol Methods; 2007; 55(3):314-22. PubMed ID: 17207642
[TBL] [Abstract][Full Text] [Related]
7. Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.
Ahn S; Kahsai AW; Pani B; Wang QT; Zhao S; Wall AL; Strachan RT; Staus DP; Wingler LM; Sun LD; Sinnaeve J; Choi M; Cho T; Xu TT; Hansen GM; Burnett MB; Lamerdin JE; Bassoni DL; Gavino BJ; Husemoen G; Olsen EK; Franch T; Costanzi S; Chen X; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1708-1713. PubMed ID: 28130548
[TBL] [Abstract][Full Text] [Related]
8. Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors.
Deng H; Sun H; Fang Y
J Pharmacol Toxicol Methods; 2013; 68(3):323-33. PubMed ID: 23933114
[TBL] [Abstract][Full Text] [Related]
9. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
10. A reporter assay for G-protein-coupled receptors using a B-cell line suitable for stable episomal expression.
Saeki S; Kunitomo H; Narita Y; Mimura H; Nishi T; Sasaki K
Anal Biochem; 2010 May; 400(2):163-72. PubMed ID: 20122890
[TBL] [Abstract][Full Text] [Related]
11. Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor.
Woo AY; Song Y; Zhu W; Xiao RP
Br J Pharmacol; 2015 Dec; 172(23):5477-88. PubMed ID: 25537131
[TBL] [Abstract][Full Text] [Related]
12. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
13. Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors.
Ferrie AM; Sun H; Zaytseva N; Fang Y
Sci Rep; 2014 Jan; 4():3828. PubMed ID: 24451999
[TBL] [Abstract][Full Text] [Related]
14. Resonant waveguide grating biosensor for whole-cell GPCR assays.
Fang Y; Ferrie AM; Tran E
Methods Mol Biol; 2009; 552():239-52. PubMed ID: 19513654
[TBL] [Abstract][Full Text] [Related]
15. Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy.
van der Westhuizen ET; Breton B; Christopoulos A; Bouvier M
Mol Pharmacol; 2014 Mar; 85(3):492-509. PubMed ID: 24366668
[TBL] [Abstract][Full Text] [Related]
16. Examination of ligand-induced conformational changes in the beta2 adrenergic receptor.
Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
Life Sci; 1998; 62(17-18):1509-12. PubMed ID: 9585127
[TBL] [Abstract][Full Text] [Related]
17. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
Galandrin S; Bouvier M
Mol Pharmacol; 2006 Nov; 70(5):1575-84. PubMed ID: 16901982
[TBL] [Abstract][Full Text] [Related]
18. High-throughput analysis of ligand-induced internalization of β2-adrenoceptors using the coiled-coil tag-probe method.
Takeda Y; Yano Y; Matsuzaki K
Anal Chem; 2012 Feb; 84(3):1754-9. PubMed ID: 22243418
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers.
Lavoie C; Hébert TE
Can J Physiol Pharmacol; 2003 Feb; 81(2):186-95. PubMed ID: 12710533
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors.
Lee PH; Gao A; van Staden C; Ly J; Salon J; Xu A; Fang Y; Verkleeren R
Assay Drug Dev Technol; 2008 Feb; 6(1):83-94. PubMed ID: 18336088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
